Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IACH MATH 2020 | Management of chronic GvHD

Zinaida Perić • 25 Jun 2020
IACH MATH 2020
General Ibrutinib

Zinaida Perić, MD, PhD, University Hospital Centre Zagreb, School of Medicine, Zagreb, Croatia, discusses the management of chronic graft-versus-host disease (GvHD) and what is on the horizon for patients. Dr Perić highlights the need for a multidisciplinary approach to chronic GvHD management as well as the importance of regular evaluations. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Zinaida Perić

Advances in chronic GvHD management
2:34
Advances in chronic GvHD management
Zinaida Perić • 28 Sep 2021
Ibrutinib, ruxolitinib & belumosudil for SR-cGvHD
2:56
Ibrutinib, ruxolitinib & belumosudil for SR-cGvHD
Zinaida Perić • 28 Sep 2021
Next steps in chronic GvHD
2:13
Next steps in chronic GvHD
Zinaida Perić • 28 Sep 2021
Amniotic membrane transplantation in ocular GvHD
6:02
Amniotic membrane transplantation in ocular GvHD
Zinaida Perić • 25 Jun 2020

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals